Effect of Sugared Chewing Gum on Gastrointestinal Recovery After Major Colorectal Surgery
NCT ID: NCT01559662
Last Updated: 2012-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
114 participants
INTERVENTIONAL
2010-08-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sugared Chewing Gum
Patient asked to chew sugared chewing gum postoperative day 1 to 7, 3 times a day, 45 minutes at a time
Sugared Chewing Gum (Juicy Fruit)
One stick of gum, 3 times daily from Postoperative day 1 to 7
No Gum
No gum given, routine postoperative care provided
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sugared Chewing Gum (Juicy Fruit)
One stick of gum, 3 times daily from Postoperative day 1 to 7
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) Class I-III (Appendix III);
* Due to undergo small and/or large partial bowel resection via laparotomy or laparoscopy
Exclusion Criteria
* American Society of Anesthesiologists (ASA) Class IV or V;
* History of abdominal carcinomatosis
* History of radiation enteritis
* Children \< 18 or adults \> 85 years of age
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cedars-Sinai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Phillip Fleshner MD
Pricipal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Phillip Fleshner, MD
Role: PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedars Sinai Medical Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSMCGumStudy
Identifier Type: -
Identifier Source: org_study_id